Skin Clearance and Itch Relief in Black or African American Patients with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s615. https://doi.org/10.25251/9qs79351